Abstract: A data receiving device may include a dummy stage block. The dummy stage block may include m dummy stages, wherein m is a natural number greater than or equal to two. Each of the m dummy stages may be configured to remove inter-symbol interference (ISI) from a dummy input signal using dummy coefficient information to generate a dummy output signal free of the ISI. Each of the m dummy stages may be further configured to output the dummy output signal. A normal stage block may include n normal stages, wherein n is a natural number greater than or equal to two. Each of the n normal stages may be configured to remove ISI from an input signal using coefficient information to generate an output signal free of the ISI and may be further configured to output the output signal.

Abstract: A 3-dimensional (3D) printing device using a support body composition including a curing agent includes a support body, a structure body, and a controller, in which the support body composition includes a curing agent configured to cure the structure body.

Abstract: The present application relates to an orally administered pharmaceutical composition or kit for eradicating Helicobacter pylori, including a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition and kit of the present invention may further include a ?-lactam antibiotic and/or a gastric acid inhibitor.

Abstract: A pharmaceutical composition for treating Clostridioides difficile Infection (CDI), and a method for producing same. The pharmaceutical composition includes a complex of clay minerals, such as bentonite, and antibiotics, such as vancomycin. Accordingly, the pharmaceutical composition has an excellent treatment effect on CDI even with a significantly smaller amount of each of the existing antibiotics and clay minerals than the maximum recommended daily intake thereof, and has the effect of reducing side effects that can be caused by the massive intake of the antibiotics and clay minerals.

Abstract: According to one embodiment of the present invention, provided is a drug-clay mineral complex, in which the complex comprises a phospholipid, and the drug has an amine group.

Abstract: A drug and layered silicate composite is provided. The drug and layered silicate contains layered silicate powders and a drug compound bound to between layers of the silicate powders, wherein the drug compound is present in an amorphous state in the composite. Using such a composite may significantly improve absorption and bioavailability of a sorafenib compound.

Abstract: Disclosed are a controlled-release composition for oral administration comprising a complex of a hydrophilic alpha adrenergic blocker compound or its salt; and a clay mineral, and a method for preparing the same. The composition of the present disclosure has an in vivo release rate controlled further than that of conventional alpha adrenergic blocker compounds, thereby preventing side effects caused by a rapid increase in plasma drug concentration.

Abstract: Provided is a cosmetic composition comprising bentonite as an active ingredient. The cosmetic composition according to the present disclosure reduces the expression of inflammatory mechanism proteins and inflammatory mechanism genes in keratinocytes and hypodermal cells, exhibits an anti-inflammatory function, increases the moisture content of the skin, reduces redness in the skin, and increases the brightness of the skin, thereby being effective in skin whitening and skin moisturizing.

Abstract: Disclosed is an orally-administered pharmaceutical composition or kit for eradicating Helicobacter pylori comprising a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition or kit of the present disclosure may further comprise a ?-lactam antibiotic and/or a gastric acid-suppressive agent.

Abstract: Provided is a pharmaceutical composition for preventing or treating metabolic bone diseases, containing bentonite as an active ingredient. The present disclosure relates to a composition for inhibiting bone resorption of osteoclasts and simultaneously, promoting bone formation of osteoblasts to be usable in the prevention or treatment of metabolic bone diseases such as osteoporosis, osteomalacia, osteopenia and bone atrophy.

Abstract: The present invention relates to a pharmaceutical composition for prevention, alleviation, and treatment of inflammatory bowel disease, the composition comprising a complex of a compound of Chemical Formula 1 or a pharmaceutically acceptable salt thereof and a clay mineral; a method for prevention, alleviation, and treatment of inflammatory bowel disease by using same; and a preparation method of the pharmaceutical composition.

Abstract: The present invention relates to a composition for oral administration with controlled release properties, comprising a complex of a compound of Chemical Formula 1 or a pharmaceutically acceptable salt thereof; and a clay mineral, and a method for preparing same.

Abstract: A composition for dyeing a bentonite, which includes a plant-derived polyphenol, and a method for dyeing a bentonite using the composition are provided. A composition for dyeing a bentonite, which includes a polyphenol such as lignin, pectin, tannin, and catechin, as a plant-derived material, and a method for dyeing a bentonite using the composition are provided.

Abstract: The present application relates to an orally administered pharmaceutical composition or kit for eradicating Helicobacter pylori, including a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition and kit of the present invention may further include a ?-lactam antibiotic and/or a gastric acid inhibitor.

Abstract: A rack having scalability and compatibility may be configured to reversibly adjusted to be reversibly configured to support various computerized equipment having various sizes and power supply schemes without adjusting an outer volume boundary of the rack and without replacement of the rack. The rack may include a main frame and an additional frame. The main frame may structurally support computerized equipment having a particular dimension that is a first size within an enclosure that is a first enclosure at least partially defined by the main frame. The additional frame may reversibly couple with the main frame to adjust the enclosure to be a second enclosure at least partially defined by the at least one additional frame to reversibly configure the main frame to store computerized equipment having the particular dimension that is a second size that is different from the first size.

Abstract: A method for synthesizing high purity montmorillonite is disclosed. According to this synthesis method, bentonite is dissolved in aqua regia to produce a solution and then sodium hydroxide (NaOH) is added to the solution to produce a mixed solution. Then, the mixed solution is kept in a sealed state at a temperature of 90° C. inclusive to 100° C. exclusive to synthesize montmorillonite crystals.

Abstract: A cooling system and associated method may be used to perform cooling using the hydrothermal energy of supply water stored in a supply water tank that is to be complementarily supplied to a cooling tower of a freezer.

Abstract: A drug and layered silicate composite is provided. The drug and layered silicate contains layered silicate powders; and a drug compound bound to between layers of the silicate powders, wherein the drug compound is present in an amorphous state in the composite. Using such a composite may significantly improve absorption and bioavailability of a sorafenib compound.

Abstract: A cooling air supplying booth apparatus for supplying cooling air to pieces of equipment in a rack unit includes a first frame and a plurality of plates. The first frame forms edges of a cuboid. The plates are fixed to the first frame and disposed at four of sides of the cuboid and form a cooling air moving path. A cooling plate includes at least one fan and is disposed at the bottom of the first frame opposite the top side of the first frame. Cooling air is supplied to the cooling air moving path through the fan, and supplied to the equipment through an outlet side in the cooling air supplying booth apparatus.

Abstract: A method for synthesizing high purity montmorillonite is disclosed. According to this synthesis method, bentonite is dissolved in aqua regia to produce a solution and then sodium hydroxide (NaOH) is added to the solution to produce a mixed solution. Then, the mixed solution is kept in a sealed state at a temperature of 90° C. inclusive to 100° C. exclusive to synthesize montmorillonite crystals.